NasdaqCM - Delayed Quote USD

Coeptis Therapeutics Holdings, Inc. (COEPW)

Compare
0.0287
+0.0071
+(32.87%)
At close: January 10 at 4:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
75.0000
30.7610
Cost of Revenue
--
--
--
--
964.2170
Gross Profit
--
--
--
75.0000
-933.4560
Operating Expense
11,258.2430
21,491.1250
34,195.9640
14,120.9320
5,779.7550
Operating Income
-11,258.2430
-21,491.1250
-34,195.9640
-14,045.9320
-6,713.2110
Net Non Operating Interest Income Expense
-331.3190
-107.6850
-218.4120
-187.1330
-148.1920
Other Income Expense
-31.6720
332.2730
-3,159.8410
783.7860
-2,294.8830
Pretax Income
-11,621.2360
-21,266.5370
-37,574.2170
-13,449.2800
-9,156.2860
Net Income Common Stockholders
-11,621.2360
-21,266.5370
-37,574.2170
-13,449.2800
-9,156.2860
Diluted NI Available to Com Stockholders
-11,621.2360
-21,266.5370
-37,574.2170
-13,449.2800
-9,156.2860
Total Operating Income as Reported
-11,258.2430
-21,491.1250
-34,195.9640
-14,045.9320
-6,861.4030
Total Expenses
11,258.2430
21,491.1250
34,195.9640
14,120.9320
6,743.9720
Net Income from Continuing & Discontinued Operation
-11,621.2360
-21,266.5370
-37,574.2170
-13,449.2800
-9,156.2860
Normalized Income
-11,640.2290
-21,834.2870
-34,180.6750
-13,447.2800
-9,156.2860
Interest Expense
331.3190
107.6850
218.4120
187.1330
148.1920
Net Interest Income
-331.3190
-107.6850
-218.4120
-187.1330
-148.1920
EBIT
-11,289.9170
-21,158.8520
-37,355.8050
-13,262.1470
-9,008.0940
EBITDA
-10,291.1940
-20,157.6150
-36,354.4210
-12,814.7340
-8,684.6660
Reconciled Cost of Revenue
--
--
--
--
964.2170
Reconciled Depreciation
998.7230
1,001.2370
1,001.3840
447.4130
323.4280
Net Income from Continuing Operation Net Minority Interest
-11,621.2360
-21,266.5370
-37,574.2170
-13,449.2800
-9,156.2860
Total Unusual Items Excluding Goodwill
18.9930
567.7500
-3,393.5420
-2.0000
--
Total Unusual Items
18.9930
567.7500
-3,393.5420
-2.0000
--
Normalized EBITDA
-10,310.1870
-20,725.3650
-32,960.8790
-12,812.7340
-8,684.6660
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DOSEF Doseology Sciences Inc.
0.1405
0.00%
 
DRMAW Dermata Therapeutics, Inc.
0.0149
+34.23%
 
GSTC GlobeStar Therapeutics Corporation
0.0004
+16.67%
 
ATNFW 180 Life Sciences Corp.
0.0100
-4.76%
 
EVLO Evelo Biosciences, Inc.
0.0005
0.00%
 
NLSPW NLS Pharmaceutics AG
0.0162
-6.36%
 
CDIOW Cardio Diagnostics Holdings, Inc.
0.0780
-2.26%
 
ENDV Endonovo Therapeutics, Inc.
0.0004
0.00%
 
JSPRW Jasper Therapeutics, Inc.
0.1600
+4.92%
 
NRX.V NurExone Biologic Inc.
0.6800
+4.62%